Marketing Pristiq: The Advertising Challenge


IBS CDC IBS CDC IBS CDC IBS CDC RSS Feed
  
Case Studies | Case Study in Business, Management, Operations, Strategy, Case Study

ICMR HOME | Case Studies Collection

Case Details:

Case Code : MKTG229
Case Length : 26 Pages
Period : 2005-2009
Pub Date : 2009
Teaching Note :Not Available
Organization : Wyeth
Industry : Pharmaceuticals
Countries : US

To download Marketing Pristiq: The Advertising Challenge case study (Case Code: MKTG229) click on the button below, and select the case from the list of available cases:





Price:
For delivery in electronic format: Rs. 400;
For delivery through courier (within India): Rs. 400 + Rs. 25 for Shipping & Handling Charges

» Marketing Case Studies
» Marketing Management Short Case Studies
» View Detailed Pricing Info
» How To Order This Case
» Business Case Studies
» Case Studies by Area
» Case Studies by Industry
» Case Studies by Company


Please note:

This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.

<< Previous

Introduction Contd...

Wyeth promoted Pristiq in several ways. In its marketing communications, Wyeth stated that Pristiq was superior to the other anti-depressants including its own drug Effexor XR. It highlighted the metabolic advantages and lack of drug interaction potential of Pristiq over other anti-depressants, while promoting it to physicians and later to the consumers. Wyeth also priced both the 50 mg and the 100 mg dosage versions of Pristiq at 20% less than the price it charged for a 75 mg version of Effexor XR. Wyeth carried out several marketing campaigns to promote Pristiq. For the first year, the company concentrated on promoting the drug only to physicians, after which it started advertising to consumers.

The major challenge faced by Wyeth while promoting the drug to consumers was to ensure that its campaign met the new guidelines of advertising proposed by the US Food and Drug Administration4 (FDA) to pharmaceutical companies.

Analysts were skeptical about the benefits provided by Pristiq as compared to other anti-depressants available in the market. Some analysts were also unsure about the effectiveness of the marketing campaign undertaken by Wyeth to promote Pristiq...

 Excerpts >>

4] Matthew Arnold, "For Pristiq, Wyeth Deploys Wind-up Doll," www.mmm-online.com, June 10, 2009.

  

Case Studies Links:- Case Studies, Short Case Studies, , Simplified Case Studies.

Other Case Studies:- Multimedia Case Studies, Cases in Other Languages.

Business Reports Link:- Business Reports.

Books:- Textbooks, Workbooks, Case Study Volumes.